Free pharmacology study map
Learn the language and mechanisms behind medication therapy before nursing-school drug classes become more detailed, while keeping dosage calculations in their own study track.
Learn the difference between generic and brand names, how drug-class names can hint at mechanism, and why indication and mechanism should be separated in study notes.
Follow absorption, distribution, metabolism and excretion to understand how route, protein binding, liver function and kidney function influence drug exposure.
Study agonists, antagonists, receptor selectivity, dose-response relationships and therapeutic versus adverse effects at the target tissue.
Compare oral, sublingual, enteral, topical, inhaled, subcutaneous, intramuscular and intravenous routes by onset, absorption and practical safety considerations.
Distinguish expected side effects, harmful adverse reactions, true allergy, toxicity and drug interactions so medication risk is described accurately.
Build an introductory framework for how common drug groups affect sympathetic and parasympathetic signaling, the central nervous system and cardiovascular physiology.
Learn why certain medications require extra safeguards, independent checks, precise communication and careful monitoring rather than relying on memorization alone.
Review controlled-drug concepts and common medication-language risks, including abbreviations and shorthand that can create preventable interpretation errors.
Connect accurate medication histories, reconciliation, adherence barriers and clear patient education with safer transitions of care and fewer medication errors.
Guest access stays fully free. Create a free account to keep module completion and study preferences synced on every device. No paid subscription is required for Pre-Nursing.
Pre-Nursing stays free. Progress is optional.
Start your first module to build momentum and unlock personalized recommendations.
Suggested next in sequence: medical-terminology
Paid NurseNest plans add full question banks, mocks, and pathway-scoped lessons once you are comfortable with the basics here.
Set a likely route on the study planning page to personalize these links.
Focus on foundations here; we’ll keep exam prep one click away.
A mechanistically grounded survey of pharmacology for pre-nursing students — covering drug naming, ADME kinetics, receptor pharmacology, adverse reactions, autonomic and CNS pharmacology, cardiovascular agents, ISMP high-alert medication safety, routes of administration, controlled substances, medication abbreviations, patient teaching, reconciliation, and nursing school exam traps.
Visual learning
Connect medication purpose, route, timing, expected response, adverse effects, and patient teaching.
Before
Check order + patient
During
Right dose + route
After
Monitor response
Purpose
Know why the medication is ordered and what outcome is expected.
Patient factors
Age, allergy, pregnancy, renal function, liver function, and weight can change safety.
Route and timing
Route affects onset, absorption, monitoring, and teaching.
Monitor response
Watch for therapeutic effect and adverse effects.
Teach safety
Explain what to report, what to avoid, and how to take the medication correctly.
Clinical connection
Safe medication learning begins with what the drug should do and what finding would indicate harm.
Pharmacokinetics vs pharmacodynamics, naming systems, and suffix patterns
Pharmacokinetics (PK)
What the body does to the drug: Absorption → Distribution → Metabolism → Excretion (ADME). Describes drug concentration over time.
Pharmacodynamics (PD)
What the drug does to the body: receptor binding, mechanism of action, dose-response relationships, therapeutic and toxic effects.
Drug Naming: Three Layers
Chemical name
Full IUPAC structure — rarely used clinically
Generic name
Nonproprietary; used on NCLEX, nursing orders, drug references (e.g., metoprolol)
Brand/Trade name
Manufacturer's name, capitalized (e.g., Lopressor). Multiple brands per generic
Drug Suffix → Class Decoder (20 Suffixes)
Why Nurses Use Generic Names on NCLEX
NCLEX and clinical orders use generic names exclusively. A patient's medication list from the pharmacy may show brand names, but nursing drug references, the MAR, and NCLEX questions use generics. Knowing the suffix tells you the drug class — if you see 'metop-', you know it's a beta-blocker and can anticipate: hold for HR <60, never stop abruptly, monitor for bronchospasm.
A patient is prescribed 'losartan.' Based on its suffix, this drug belongs to which class?
Absorption, Distribution, Metabolism, Excretion
First-Pass Effect & Bioavailability
First-pass effect: oral drugs absorbed from the GI tract travel through the portal vein to the liver before reaching systemic circulation. The liver metabolizes a portion before it can act — this reduces bioavailability. Sublingual (nitrates), transdermal, rectal, and IV routes bypass the liver entirely, explaining why IV doses are often much lower than oral doses for the same drug.
Routes bypassing first-pass (IV, sublingual, transdermal, inhalation) have higher bioavailability. Oral bioavailability of nitroglycerin ~1% — sublingual gives 38–80%. pH affects ionization and absorption: weakly acidic drugs (aspirin) absorb well in acidic stomach; weakly basic drugs (morphine) absorb better in alkaline small intestine. Food effects: fatty meals enhance lipophilic drug absorption (tacrolimus); calcium in dairy chelates tetracycline → 50% absorption reduction.
Protein binding (primarily albumin): only FREE (unbound) drug is pharmacologically active. Low albumin (liver failure, malnutrition, nephrotic syndrome) → more free drug → ↑ effect and ↑ toxicity risk. Blood-brain barrier (BBB): tight junctions + efflux pumps block most drugs. Lipophilic, small, uncharged drugs cross best (diazepam, propranolol). Placental transfer: lipophilic drugs cross freely — explain why alcohol, opioids, and many medications are teratogenic. Volume of distribution (Vd): large Vd = drug distributes widely into tissues (lipophilic drugs); small Vd = drug stays in plasma (warfarin, aminoglycosides).
Phase I (CYP450 enzymes): oxidation, reduction, hydrolysis → often add -OH (increase polarity). Phase II: conjugation (glucuronidation, sulfation, acetylation) → water-soluble conjugates for excretion. CYP inducers (↑ metabolism → ↓ drug levels → treatment failure): rifampin, phenytoin, carbamazepine, St. John's Wort. CYP inhibitors (↓ metabolism → ↑ drug levels → toxicity): fluconazole, erythromycin, grapefruit juice, amiodarone. Prodrugs require metabolism for activation: codeine → morphine via CYP2D6 (ultrarapid metabolizers can have fatal response); clopidogrel → active metabolite via CYP2C19 (poor metabolizers lack antiplatelet effect).
Kidneys excrete water-soluble drug metabolites by glomerular filtration and tubular secretion. Renal impairment accumulates drugs — dose-adjust when CrCl <30 mL/min (or <60 for renally cleared narrow TI drugs). Narrow TI drugs requiring renal dose adjustment: digoxin, lithium, metformin (hold if CrCl <30, lactic acidosis risk), gabapentin, methotrexate, aminoglycosides. Half-life (t½): time for plasma concentration to decrease 50%. 5 half-lives to reach steady state (accumulation) AND to eliminate 97% of drug. Practical: digoxin t½ = 36-48h → takes 7-10 days to reach steady state.
Grapefruit + CYP3A4: A Hidden Drug Interaction
Grapefruit juice contains furanocoumarins that irreversibly inhibit intestinal CYP3A4 — the enzyme responsible for metabolizing ~50% of all drugs. Inhibiting this enzyme increases bioavailability of statins (simvastatin, atorvastatin) and dihydropyridine CCBs (amlodipine, felodipine), risking myopathy or dangerous hypotension. Even a single glass of grapefruit juice can inhibit CYP3A4 for up to 72 hours. Teach patients to avoid grapefruit with any -statin or -dipine medication.
Narrow Therapeutic Index Drugs — Monitor Closely
Narrow therapeutic index drugs require close monitoring because the toxic dose is close to the therapeutic dose. Lithium (0.6–1.2 mEq/L): toxicity with dehydration, NSAIDs, or thiazides. Digoxin (0.5–2.0 ng/mL): toxicity worsened by hypokalemia — always check K+ before giving. Warfarin (INR 2–3): dozens of food and drug interactions. Phenytoin (10–20 mcg/mL): zero-order kinetics — small dose increases cause disproportionate level rises. Aminoglycosides: peak and trough levels, nephrotoxicity and ototoxicity monitoring essential.
How drugs bind receptors and produce effects
Receptor Types
Agonist vs Antagonist vs Partial Agonist
Potency vs Efficacy vs Therapeutic Index
components.interactiveLearning.terms
components.interactiveLearning.definitions
Buprenorphine has a 'ceiling effect' on respiratory depression because it is a:
Predictable, idiosyncratic, and drug-drug interactions
Type A — Predictable (70% of ADRs)
Dose-related, extension of pharmacological effect. Predictable, manageable by dose adjustment. Examples: beta-blocker bradycardia, insulin hypoglycemia, anticoagulant bleeding, diuretic hypokalemia, NSAID GI bleed. Most NCLEX adverse effects are Type A.
Type B — Idiosyncratic / Immune-Mediated
Unpredictable, not dose-related, often immunologic. Examples: penicillin anaphylaxis (IgE-mediated), clozapine agranulocytosis (weekly ANC monitoring required), halothane hepatotoxicity, Stevens-Johnson syndrome (allopurinol, sulfonamides, anticonvulsants).
Abrupt Discontinuation Syndromes — Teach Every Patient
Never stop these medications abruptly: Corticosteroids (chronic use suppresses the HPA axis — adrenal crisis with sudden cessation), Beta-blockers (rebound tachycardia, hypertension, angina, MI risk), Opioids (withdrawal syndrome: diaphoresis, piloerection, diarrhea, tachycardia), Benzodiazepines (seizures, delirium — most dangerous withdrawal). Teach every patient on long-term therapy to taper under provider guidance.
Critical Food-Drug Interactions
Serotonin Syndrome: Recognize and Act
Serotonin syndrome results from excess serotonergic activity, classically from combining SSRIs or SNRIs with MAOIs, triptans, linezolid, tramadol, or St. John's Wort. Classic triad: altered mental status (agitation, confusion) + neuromuscular abnormalities (clonus, hyperreflexia, tremor) + autonomic instability (hyperthermia, tachycardia, diaphoresis). Distinguish from neuroleptic malignant syndrome by time course (rapid onset, hours) and presence of clonus vs rigidity. Treatment: remove offending agent, cyproheptadine (5-HT2A antagonist), benzodiazepines, supportive cooling.
A patient on warfarin starts eating large amounts of leafy greens daily. You would expect their INR to:
SNS, PSNS, adrenergic and cholinergic drugs
SNS — Fight-or-Flight (NE, Epi)
PSNS — Rest-and-Digest (ACh, Muscarinic)
Selective β1 (metoprolol, atenolol, bisoprolol): ↓ HR, ↓ contractility, ↓ renin → used in HTN, post-MI (mortality benefit), HFrEF, atrial fibrillation rate control, angina. Non-selective (propranolol, carvedilol): also blocks β2 → contraindicated in asthma/COPD (bronchospasm). ALL beta-blockers: NEVER stop abruptly (rebound tachycardia, angina, MI); hold if HR <60 or SBP <90; monitor blood glucose in diabetics (masks hypoglycemia signs except sweating).
Mechanism: α1 → vasoconstriction (raises BP, reduces angioedema); β1 → ↑ cardiac output; β2 → bronchodilation. First-line treatment for anaphylaxis (IM epinephrine 0.3 mg into lateral thigh, EpiPen). Also used in cardiac arrest (1 mg IV q3-5min). Side effects at high doses: hypertension, tachycardia, arrhythmias.
Short-acting β2 agonist (SABA): bronchodilation within 5 min. First-line for acute asthma and COPD exacerbation. Side effects: tachycardia (some β1 at high doses), tremor, hypokalemia (β2 shifts K⁺ into cells — important in hyperkalemia treatment via insulin + albuterol). Overuse (>2 rescue inhalers/month) signals poorly controlled asthma needing step-up therapy.
Atropine: ↑ HR (vagolysis), ↓ secretions, used in bradycardia and organophosphate poisoning. Ipratropium: inhaled bronchodilator (M3 block), COPD maintenance. Scopolamine: motion sickness (patch). Oxybutynin/tolterodine: overactive bladder. Side effects mnemonic: 'Dry as a bone, blind as a bat, red as a beet, hot as a hare, mad as a hatter, full as a flask' (dry skin, blurred vision, flushing, hyperthermia, confusion, urinary retention). Beers Criteria: HIGH risk in elderly (delirium, falls, urinary retention).
Opioids, benzodiazepines, antidepressants, antipsychotics
Opioids — μ-Receptor Agonists
Benzodiazepines — GABA-A Enhancers
SSRIs / SNRIs — Antidepressants
Antipsychotics — D2 Receptor Blockers
A patient on long-term benzodiazepines is abruptly discontinued. The most dangerous withdrawal effect is:
Antihypertensives, diuretics, anticoagulants, digoxin
ACEi (-pril): block ACE → ↓ angiotensin II → vasodilation + ↓ aldosterone → ↓ Na/water retention. Side effects: dry cough (bradykinin accumulation, 10-20% of patients — switch to ARB), angioedema (rare but STOP immediately — can be fatal), hyperkalemia (↓ aldosterone), teratogenic (category D — causes fetal renal agenesis). Indications: HTN, HFrEF (mortality benefit), post-MI (↓ remodeling), diabetic nephropathy (↓ intraglomerular pressure → renoprotective). ARBs (-sartan): block AT1 receptor directly. Same hemodynamic benefit, NO bradykinin accumulation → NO cough. Still cause hyperkalemia and fetal harm. Use when ACEi cough is intolerable.
Dihydropyridines (-dipine: amlodipine, nifedipine, felodipine): vascular smooth muscle selectivity → ↓ peripheral vascular resistance → ↓ BP. Minimal cardiac depression. Side effects: peripheral edema (vasodilation), flushing, headache. No AV block. Non-dihydropyridines (diltiazem, verapamil): cardiac selectivity → ↓ HR, ↓ AV conduction (rate control in Afib/flutter), ↓ contractility. Contraindicated: decompensated HF, pre-excitation syndromes (WPW). Verapamil causes constipation. NEVER combine non-DHP CCBs with beta-blockers → risk of complete heart block.
Loop (furosemide, bumetanide, torsemide): most potent, inhibit Na-K-2Cl transporter in loop of Henle. Hypokalemia (monitor K+), hypomagnesemia, ototoxicity (high IV doses, concurrent aminoglycosides), hyperuricemia, gout. First-line for acute pulmonary edema (HF). Thiazides (HCTZ, chlorthalidone): inhibit NCC in distal tubule. Moderate natriuresis. Hypokalemia, hypercalcemia (↑ Ca reabsorption — useful in osteoporosis), hyperuricemia, hyperglycemia (↓ insulin secretion). First-line for uncomplicated HTN. K+-sparing (spironolactone, eplerenone, amiloride, triamterene): weak diuretics. Spironolactone/eplerenone: aldosterone antagonists — mortality benefit in HFrEF. Hyperkalemia risk — avoid with ACEi/ARBs in renal failure.
Heparin (UFH): activates antithrombin III → inhibits thrombin + Xa. Monitor aPTT (therapeutic 60-100s). Antidote: protamine sulfate. Enoxaparin (LMWH): anti-Xa activity, predictable dosing, monitor anti-Xa levels in renal failure/obesity. Warfarin: inhibits vitamin K-dependent clotting factor synthesis (II, VII, IX, X, protein C/S). Monitor INR (therapeutic 2-3). Dozens of interactions. Antidotes: vitamin K (slow), FFP (fast), 4-factor PCC (fastest). DOACs (direct oral anticoagulants): dabigatran (direct thrombin inhibitor, antidote idarucizumab), rivaroxaban/apixaban/edoxaban (factor Xa inhibitors, antidote andexanet alfa). Less monitoring. Digoxin: inhibits Na+/K+-ATPase → ↑ intracellular Ca → ↑ contractility. Narrow TI: therapeutic 0.5-2.0 ng/mL. Toxicity signs: nausea, vomiting, visual halos, bradycardia, arrhythmias. Toxicity worsened by hypokalemia (K+ competes with digoxin at pump binding site) and hypomagnesemia. Antidote: digibind (digoxin-specific antibody fragments).
Key CV Monitoring Rules
ISMP list, LASA drugs, error prevention, 9 rights
High-Alert Medications: 5 That Can Kill Immediately
The five most dangerous high-alert medications in hospital settings: (1) Concentrated KCl — NEVER IV push; must be diluted and administered on a pump. IV bolus causes cardiac arrest within seconds. (2) Insulin — unit confusion and syringe type errors are common; always independent double-check. (3) Heparin — weight-based dosing; aPTT monitoring required. (4) Opioids — respiratory depression risk; naloxone must be available. (5) Neuromuscular blocking agents — patient must be intubated and ventilated; accidental administration to an awake patient causes conscious paralysis and terror.
LASA (Look-Alike, Sound-Alike) Medications
Do Not Use Abbreviations (TJC Official List)
The 9 Rights of Medication Administration
Independent Double-Check & Safe Practices
The #1 Most Preventable Medication Error
The most common and preventable medication error is administering a drug to the wrong patient. Always verify two patient identifiers before every administration — name AND date of birth (or medical record number). Do not rely on room number or bed label. The second most common preventable error is wrong dose due to decimal point confusion (0.1 mg vs 1.0 mg) — never use trailing zeros (1.0 mg → write 1 mg), always use leading zeros (0.1 mg, never .1 mg). The abbreviation 'U' for units has caused 10-fold overdoses (read as zero) — always write out 'units'.
A prescriber writes 'insulin 10U subcutaneous.' The 'U' abbreviation is dangerous because:
A patient with low serum albumin (2.0 g/dL) is started on phenytoin (highly protein-bound). What is the expected pharmacological consequence?
How drugs reach the body
The route of administration determines how quickly a drug reaches its target, its bioavailability, and nursing safety responsibilities.
Onset 30–90 min. Bioavailability varies. Cannot use if patient is NPO or unconscious. Extended-release tablets NEVER crushed. First-pass reduces systemic concentration — oral morphine dose is much higher than IV dose.
Sublingual (under tongue): nitroglycerin onset 1–3 min. Buccal (between cheek and gum): sustained release. Both bypass hepatic first-pass. Teach patient: do not swallow, no food or drink until dissolved.
IV: fastest, 100% bioavailability, cannot be recalled. IM: deltoid ≤1 mL, ventrogluteal ≤3 mL. SubQ: insulin, heparin, epinephrine auto-injector. ID (intradermal): TB test, 0.1 mL, form bleb.
Transdermal: bypasses first-pass, slow sustained release (fentanyl patch, nicotine, scopolamine). Remove old patch before new. Inhaled: rapid for respiratory (albuterol onset 5 min). Rinse mouth after inhaled steroids to prevent oral thrush.
Never give oral medications to unconscious patients
Administering oral medications to a patient who cannot swallow or maintain their airway risks aspiration pneumonia. If a patient is unconscious, confused, or has impaired gag reflex, hold oral medications and notify the provider immediately.
A patient is prescribed sublingual nitroglycerin for chest pain. The nurse should teach the patient to:
What every nursing student must know
Medication order errors kill patients. Understanding safe abbreviation practices and order interpretation is a core nursing safety competency.
Common Prescription Abbreviations
PO (by mouth) · SL (sublingual) · IV (intravenous) · IM (intramuscular) · SubQ (subcutaneous) · PRN (as needed) · STAT (immediately) · QD (daily) · BID (twice daily) · TID (three times daily) · QID (four times daily) · AC (before meals) · PC (after meals) · HS (at bedtime)
Do NOT Use (ISMP/JCAHO)
U (units → write "units", looks like 0) · IU (write "international units") · QD/QOD (write "daily"/"every other day") · Trailing zero (1.0 mg → write 1 mg) · Naked decimal (.5 mg → write 0.5 mg) · MS/MSO4/MgSO4 (spell out morphine sulfate / magnesium sulfate)
When in doubt, write it out
The abbreviation 'U' has been misread as 0 (zero), resulting in 10-fold insulin overdoses. The ISMP Do Not Use list exists because these errors have caused patient deaths. Always write 'units' — never 'U'. Always use a leading zero (0.5 mg) — never a bare decimal (.5 mg). Never write a trailing zero (1 mg — not 1.0 mg).
A physician writes an order for 'Humulin R 10U subcutaneous.' What is the nurse's correct action?
Legal classification and nursing responsibilities
The DEA classifies controlled substances into five schedules based on medical use and abuse potential. Nurses have specific legal responsibilities for controlled substance management.
Examples: heroin, LSD, peyote, MDMA, marijuana (federally). Cannot be prescribed. Research use only with special DEA registration.
Examples: morphine, oxycodone, fentanyl, hydromorphone, cocaine (topical), methylphenidate, amphetamine. Written or electronic prescription only. No phone-in refills. Emergency verbal order must be followed by written Rx within 7 days.
Schedule III: Tylenol with codeine, buprenorphine (Suboxone), testosterone. Schedule IV: benzodiazepines, zolpidem (Ambien), tramadol, carisoprodol. Phone-in refills generally permitted (limited refills).
Examples: cough preparations with small amounts of codeine, pregabalin (Lyrica). Some states allow OTC purchase with pharmacist oversight.
Nursing controlled substance responsibilities
Count narcotics at every shift change with a witness (two nurses verify count). Document every dose removed and every dose administered. Unused portions must be wasted in the presence of a witness — both nurses sign. Report any discrepancy immediately to the charge nurse and pharmacy. Drug diversion (taking controlled substances for personal use) is a felony and results in license revocation. Never leave a controlled substance unattended.
Safety at every transition of care
Patient medication education and reconciliation at transitions of care are among the most important safety activities nurses perform. Errors at these points account for a significant proportion of preventable harm.
Teach-Back Method
Do NOT ask: "Do you understand?" (always answered yes). Instead ask: "Can you tell me in your own words how you'll take this medication?" or "Can you show me how to use this inhaler?" The teach-back method verifies learning. If the patient cannot demonstrate understanding, re-teach with different language or visual aids.
Key Teaching Points for Every Medication
Generic name and purpose · Dose and schedule · How to take (with/without food, avoid grapefruit) · What to monitor at home (BP, glucose, INR) · Expected vs reportable side effects · What to do if a dose is missed · Storage (light/temperature-sensitive) · Never stop without consulting provider
Medication Reconciliation
Compare ALL medications (Rx, OTC, herbals, supplements, patches, eye drops, inhalers) at EVERY transition: admission → transfer → procedure → discharge. Common errors: omission, duplication, dose discrepancy. Herbals matter: St. John's Wort induces CYP450 (↓drug levels), ginkgo + warfarin (↑bleeding).
Why reconciliation errors peak at transitions
Patients move between settings (ED → ICU → floor → home) and providers. Each transition introduces risk that a medication will be omitted, duplicated, or changed without intent. The BPMH (Best Possible Medication History) — a complete list including all Rx, OTC, and supplements — is the gold standard starting point. 50% of patients do not take medications as prescribed; non-adherence causes 125,000 deaths/year in the US.
After teaching a patient how to use a metered-dose inhaler (MDI), the nurse asks the patient to demonstrate the technique. This is an example of:
What the NCLEX tests that students miss
Pharmacology questions on nursing exams test application, not memorization. These are the most common reasoning traps that cost students points.
NCLEX question: 'When is it appropriate to give digoxin?' Answer: Always check apical pulse (hold if <60 in adults) AND check potassium level (hypokalemia increases toxicity risk). The action is always assessment first.
Beta-blockers are generally continued on the day of surgery (with a sip of water if NPO) to prevent rebound tachycardia and hypertension. Exception: hold if heart rate <50 or as specifically ordered. Never stop abruptly.
Cross-reactivity is ~1–2% for true penicillin allergy (not GI upset). Ask: was it rash vs. anaphylaxis? Anaphylaxis to penicillin = avoid all cephalosporins and carbapenems. Mild rash = assess carefully with provider guidance.
IV KCl given undiluted or by IV push causes fatal cardiac arrhythmia within seconds. Maximum 10–20 mEq/hour peripheral. Concentration >40 mEq/L requires central access. Pain and burning at peripheral IV site is normal — warn patient.
ACE inhibitors and alpha-1 blockers (prazosin, doxazosin) cause first-dose hypotension. Teach patients: take first dose at bedtime; rise slowly; call for help if dizzy. Monitor BP 1 hour after first dose.
Lithium competes with sodium for renal reabsorption. Low sodium diet, dehydration, NSAIDs, and thiazide diuretics all decrease renal lithium excretion → toxicity. Patients need consistent sodium intake and adequate fluid.
Patients on warfarin should NOT eliminate vitamin K foods (greens) but keep intake consistent. Sudden increase = subtherapeutic INR; sudden decrease = supratherapeutic INR. Teach: same amount of greens weekly, not zero.
When asked which medication to question or hold, look for: wrong patient (two identifiers), known allergy to drug class, dose outside safe range, route inappropriate for patient status, contraindicated drug-disease combination. Prioritize safety.
A patient prescribed digoxin 0.125 mg daily has a serum potassium of 2.9 mEq/L. The nurse's priority action is:
